Pharmaceuticals firm Zydus Lifesciences on Monday said its Rs 750 crore share buyback plan is scheduled to commence on June 23 and closes on July 6, 2022.
The drug firm, earlier known as Cadila Healthcare, has fixed July 15, 2022, as the last date for the settlement of bids on stock exchanges which may even happen early, as per a regulatory filing.
The company's board has approved the proposal to buy back a little over 1.15 crore shares, representing up to 1.13 percent of the total paid-up equity share capital of the company, for an aggregate amount of up to Rs 750 crore.
Also Read:
The Ahmedabad-based company issued a public announcement on May 24 in various newspapers for the buyback of its equity shares from the open market through the stock exchange route, a regulatory filing said.
ICICI Securities Ltd is the manager of the buyback, it said.
First Published: Jun 13, 2022 9:04 PM IST
Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!
Lok Sabha Election 2024: I.N.D.I.A. bloc to hold rally at Mumbai's BKC today
May 17, 2024 5:18 PM
In Ayodhya, voters talk of a promise fulfilled and yearning for development
May 17, 2024 2:10 PM
Fight of heavyweights in Sambalpur where farmers, weavers hold the key
May 17, 2024 12:25 PM
Odisha: Fight of heavyweights in Sambalpur where farmers, weavers hold the key
May 17, 2024 10:22 AM